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Introduction: Children undergoing hematopoietic stem cell
transplantation (HSCT) are at risk of developing vitamin D
deﬁciency (VDD). However, data on vitamin D status and its
correlation with bone mineral density (BMD) in the long
term survivors after childhood HSCT is limited. The aim of
this study was to determine the prevalence of VDD among
long term survivors after HSCT in childhood, and to evaluate
the correlations between vitamin D and BMD.
Methods: A retrospective study was carried out in patients
seen in Long Term follow-up Clinic (LTFC) at our institution
from January 2011 to July 2012. VDD and insufﬁciency (VDI)
were deﬁned as serum 25-hydroxyvitamin D (25-OHD) <15
ng/mL and 15-30 ng/mL, respectively. BMD was measured
using dual-energy radiograph absorptiometry (Hologic Del-
phi). Lumbar, total body, and hip BMD Z scores were deter-
mined using manufacturer's normative data based on age.
Spearman's correlation was performed to assess correlation
between serum 25-OHD levels and different BMD variables.
Results: Ninety eight patients underwent 103 HSCTs
between 1990 and 2010. Fifty two (53%) patients were > 5
years out of transplant. A total of 114 vitamin D levels were
recorded for the 98 patients, the median 25-OHD level was
26 (range 7 - 68 ng/mL). In 68/114 (60%) observations the 25-
OHD levels were less than < 30ng/mL. Of these, 10 (9%)
patients had VDD (levels < 15ng/mL, while 58 (51%) had VDI.
There were no signiﬁcant correlations between 25-OHD
levels and age at HSCT, gender, underlying diagnosis, type of
transplant, or development of acute or chronic GVHD (Table
2). Therewas a trend towards lower 25-OHD levels after non-
TBI based conditioning regimen (P ¼ .047). BMD was per-
formed in 83 patients (85%). Low BMD was found in nearly
one-third to half of patients tested: 29%, 54%, and 33% of the
patients had BMDlumbar, BMDhip and BMDWB Z scores of<
-1.0, respectively, while 5%, 9% and 5% of the patients had
BMDlumbar, BMDhip and BMDWB Z scores < -2.5, respec-
tively. The median Z scores of the BMDlumbar, BMDhip, and
the BMDWB were -0.3 (range - 4.2 to 2.4), -1.1 (range -3.3 to
1.9), and -0.4 (range -5.4 to 2.7) respectively. In patients with
BMD < -2.5 and < -1.0, the corresponding median 25-OHD
was 26 (range 7 - 62 ng/mL) and there was no signiﬁcant
association. Spearman correlation between 25-OHD D level,
BMDWB and BMDlumbar showed a correlation coefﬁcient of
-0.24 (P value: 0.0409) and -0.22 (P value: 0.0546) respec-
tively. There was no correlation between normal vitamin D
levels, VDI and VDD with BMD of the hip, lumbar spine and
whole body.
Discussion: Low 25-OHD (<30 ng/mL) was common (60%) in
long term survivors after HSCT during childhood. Similar to
other reports, VDD and VDI was seen in 9%, and 51% of the
patients respectively. There was only a weak correlation of
the 25-OHD levels with BMD of whole body and the lumbar
spine, suggesting that factors other than hypovitaminosis D
might have contributed to low BMD. There was a small trend
of lower 25-OHD levels after non-TBI based conditioning.199
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Background: Consultation for abdominal pain (AP) in pedi-
atric patients following allogeneic hematopoietic stem cell
transplant (HSCT) is common. Non HSCT related GI inﬂam-
mation (infectious and non-infectious) has been associated
with post-inﬂammatory abdominal pain and functional
gastrointestinal disorders (FGID) in ashighas60%of cases. The
presence of AP and FGIDs after HSCT has not been described.
We hypothesized that AP is frequent after HSCT given the
inﬂammation from conditioning, GVHD and infection.
Methods: Patients >2 years from HSCT were offered
a Questionnaire of Pediatric Gastrointestinal Symptoms.
Thosewith active gut GVHDwere excluded. After completing
the surveys, chart reviews were performed focusing on
demographics, transplant characteristics, adverse events and
long-term outcomes.
Results: 48 patients completed the survey;7 (15%) had
abdominal complaints. 3 patients were diagnosed with AP
related FGID (dyspepsia, IBS, functional abdominal pain); 4
had AP that did not ﬁt criteria for diagnosis. The group with
AP were transplanted for high risk malignancy (71%) e
ALL(2), AML (1), Anaplastic Lymphoma (1) and Stage IV
Neuroblastoma(1). There was an increased incidence of total
body irradiation (TBI) containing regimens (57% vs 39%) in
patients with AP, but conditioning regimen intensity ie.
myeloablative versus reduced intensity (MA/RIC) was not
associated with AP. There was an increased incidence of
aGVHD (43.9% vs 29.3%), however surprisingly incidence of
GI aGVHD was equal between groups. Those with AP had
a higher incidence of second transplants (28.5% vs 4.9%),
which were performed for relapse. The AP group also had
more frequent abdominal infections (40% vs. 15%). The time
interval from HSCT in the AP/FGID group is shorter (4 years),
compared to the non-AP group (6 years), P ¼ .029; however
there were no other signiﬁcant demographic differences
between the two groups.
Conclusions: AP and FGIDs are common after HSCT in chil-
dren.APwasmore frequent inpatients<5yrs fromHSCT.Data
suggested that TBI, abdominal infections and relapse may be
associated with later development of abdominal pain. Larger
studies are needed for further evaluation and to conﬁrm these
ﬁnding. The investigation of post-HSCT AP and FGIDs may
help understand the role of inﬂammation, stress, coping and
families on the development of functional abdominal pain.
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Abstracts / Biol Blood Marrow Transplant 19 (2013) S211eS232 S213Background: Pulmonary complications can cause consider-
able morbidity and mortality after allogeneic hematopoietic
stem cell transplantation (HCT). Other than lung trans-
plantation (LT), no speciﬁc therapies exist for end-stage lung
disease resulting from HCT-related complications such as
bronchiolitis obliterans syndrome. Here we describe the
indications and outcomes in patients who had LT after HCT
for hematologic disease.
Methods: Retrospective chart review of cases identiﬁed by
the Long-Term Follow Up (LTFU) database at the Fred
Hutchinson Cancer Research Center/Seattle Cancer Care
Alliance. This database captures information provided by
patients, primary physicians and by LTFU clinical service via
telemedicine or by medical evaluation on site. Any patient
who received a HCT at our institutionwith a reported history
of LT was included.
Results: We identiﬁed 9 recipients of allogeneic HCT
between 1971 and 2006 who subsequently received LT
between 1990 and 2010. The median age at the time of HCT
was 16 (range, 10-35) years, and the median age at the time
of LT was 34 (range, 17-44) years. The diagnosis at the time of
HCT was acute leukemia (n¼7), chronic myeloid leukemia
(n¼1) and aplastic anemia (n¼1). The median interval
between HCT and LT was 123 (range, 35-326) months. None
of the patients had evidence of the original hematologic
disorder at time of LT. Indications for LT included pulmonary
ﬁbrosis related to any history of radiation or chemotherapy
before or as part of the conditioning regimen for HCT (n¼4),
interstitial pneumonitis related to graft-versus-host-disease
(n¼1), bronchiolitis obliterans syndrome (n¼3), and primary
pulmonary hypertension (n¼1). All patients received
unilateral (n¼4) or bilateral cadaveric LT (n¼5). Survival at
one and ﬁve years after LT was 89% and 37%, respectively.
Eight of the 9 patients died at a median of 49 months (range,
2 weeks to 87 months), and 1 is alive more than two years
after LT. Deaths were attributed to chronic graft rejection
and/or pulmonary infectious complications in 6 patients and
anoxic brain injury from cardiac and pulmonary arrest in 1
patient. Information about the cause of death for 1 patient
who died 2 weeks after LT was unavailable. According to
a nationwide registry of organ transplantation (2010 OPTN/
STRT Annual Data Report), survival of all LT recipients at one
year improved from 72% in 1990 to 85% in 2008; survival at
ﬁve years improved from 39% in 1990 to 56% in 2004.
Conclusions: LT can prolong survival in some adult and
adolescent patients who suffer from end-stage pulmonary
complications after HCT. These results can help to inform
HCT patients who are considering LT. HCT patients with
progressive pulmonary disease, but otherwise in good
health, should be referred to an established LT center for
evaluation, since early identiﬁcation of good candidates for
LT may result in better survival outcomes.201
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HSCT is a clinical procedure that involves lethal risk.
However, it sometimes arises as the only possibility for
survival. Patients ﬁnd a multiplicity of side effects resultingfrom the illness and its treatment. Graft versus host disease
(GVHD) is one of themost important causes ofmorbidity after
HSCT. We designed this study in order to evaluate the impact
of graft versus host disease on QoL healtth, sexuality and
fatigue in long term survivors after HSCT. This is a prospective
seccional study of 214 long term survivors after HSCT, which
were divided in two groups for comparison: Group 1 (G1¼89)
survivors with GVHD e Group 2 (G2¼125) without GVHD. G1
was further divided into three groups according to GVHD
classiﬁcation: Group a (Ga) e acute GVHD; Group c (Gc) e
chronic GVHD; Grupo ac (Gac) acute and chronic GVHD. Level
of satisfaction about QoL, sexuality, health and fatigue were
evaluated. All patients had at least 18 years old. Scales used
were: WHOQOL, Functional Assessment of Cancer Therapy:
Fatigue FACT-F, Karnofsky Performance Status Scale and
Socioeconomic demographic survey. Level of signiﬁcance in
all scales was 95% (p  0.05) for all risk factors for QoL.
Among survivors from groups G1 and G2, there were
more males (61.8% and 67%), married (63% 54.8%), and low
socio economic status (67.4% and 61.3) patients. Both groups
had similar percentage of survivors with more than eight
years of scholarship (67%). Median age of survivor from G1
was 3910 years and from G2, 329.6 years.
Most of G1 survivors (67.4%) were 25.9 10.8 years old at
the time of transplant versus 19.510 years old for G2.
Malignant diseases were predominant at G1 (60.7%) when
compared to G2 (29.8%). At the time of the study, 73% of
survivors from G1 and 82% from G2 had 10 to 15 years after
HSCT. Pre and post HSCT Karnofsky scores were similar for
both groups: G1 (89.9% e 98.9%), G2 (83.9% e 99.2%). Survi-
vors from both groups reported satisfactionwith QoL, health,
and sexuality. 65.2% from G1 and 75.4% from G2 reported
absence of fatigue. These results show that level of satisfac-
tion of long term survivors with their QoL, health, sexuality
and fatigue were favorable in spite of having been diagnosed
with acute or chronic graft-versus-host-disease. Trans-
plantation provides an opportunity for changes in subjec-
tivity and in facing life's adversities. It is therefore crucial that
the QOL assessment can be part of the clinical protocol, once
it provides information about risk factor which allow for the
best choice of interventions.202
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Introduction: Many recipients of allogeneic haemopoietic
stem cell transplant (HSCT) & families need ongoing clinical,
psychological & rehabilitative information & support post-
transplant. Optimisation of internet resources may ensure
easy access to relevant & accurate information. The aims of
this three phase project were to (1) assess the psychosocial
needs & (2) evaluate the impact of a speciﬁcally designed
website (Allograft Information Exchange: ALLINEX) as an
adjunct to standard care post-HSCT.
Methods: The project was approved by the regional research
ethics committee.
Phase one: Assessment of post-transplant standard care
(SC) was achieved by 1) cross-sectional patient interview
